- Article type
- 22 Nov 2010
- 03 Mar 2011
- First published
- 12 Apr 2011
- This article is Open Access
genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments
A. A. Seyhan, U. Varadarajan, S. Choe, Y. Liu, J. McGraw, M. Woods, S. Murray, A. Eckert, W. Liu and T. E. Ryan, Mol. BioSyst., 2011, 7, 1974 DOI: 10.1039/C0MB00294A
This is an Open Access article. The full version of this article can be posted on a website/blog, posted on an intranet, photocopied, emailed, distributed in a course pack or distributed in Continuing Medical Education (CME) materials provided that it is not used for commercial purposes.
To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.